Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Matthew Driban, Nikita Kedia, Supriya Arora & Jay Chhablani. (2023) Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders. Expert Review of Clinical Pharmacology 16:11, pages 1125-1139.
Read now
Read now
Martina Musella, Gwenola Manic, Ruggero De Maria, Ilio Vitale & Antonella Sistigu. (2017) Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications. OncoImmunology 6:5.
Read now
Read now
Martine F. Raphael, Johannes M. P. J. Breur, Florine A. E. Vlasveld, Niels J. Elbert, Yves T. B. Liem, Moshe Kon, Corstiaan C. Breugem & Suzanne G. M. A. Pasmans. (2016) Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events – a review of the literature. Expert Opinion on Drug Safety 15:2, pages 199-214.
Read now
Read now
Iván Alvarez-Twose, Almudena Matito, Laura Sánchez-Muñoz, José Mário Morgado & Luis Escribano. (2014) Management of adult mastocytosis. Expert Opinion on Orphan Drugs 2:4, pages 321-336.
Read now
Read now
Articles from other publishers (59)
Jordan D. Lewicky, Alexandrine L. Martel, Mukul Raj Gupta, René Roy, Galaxia M. Rodriguez, Barbara C. Vanderhyden & Hoang-Thanh Le. (2023) Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential. Cancers 15:16, pages 4127.
Crossref
Crossref
Mehrdad AfaridHossein BahariFatemeh Sanie-Jahromi. (2023)
In Vitro
Evaluation of Apoptosis, Inflammation, Angiogenesis, and Neuroprotection Gene Expression in Retinal Pigmented Epithelial Cell Treated with Interferon α-2b
. Journal of Interferon & Cytokine Research 43:7, pages 299-306.
Crossref
Crossref
Zhen-Ling Liu, Huan-Huan Chen, Li-Li Zheng, Li-Ping Sun & Lei Shi. (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Jing Yung Lai, Jian Xiang Ho, Audrey Siew Foong Kow, Gengfan Liang, Chau Ling Tham, Yu-Cheng Ho & Ming Tatt Lee. (2023) Interferon therapy and its association with depressive disorders – A review. Frontiers in Immunology 14.
Crossref
Crossref
Ngoc Lan Tran, Lorena Maria Ferreira, Blanca Alvarez-Moya, Valentina Buttiglione, Barbara Ferrini, Paola Zordan, Andrea Monestiroli, Claudio Fagioli, Eugenia Bezzecchi, Giulia Maria Scotti, Antonio Esposito, Riccardo Leone, Chiara Gnasso, Andrea Brendolan, Luca G Guidotti & Giovanni Sitia. (2022) Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier. eLife 11.
Crossref
Crossref
Hooshang Faghihi, Bahman Inanloo, Arash Mirzaee, Kaveh Fadakar, Ahmad Mirshahi, Nazanin Ebrahimiadib, Fariba Ghassemi, Fatemeh Bazvand, Abdulrahman Amini, Masoud Mirghorbani, Shahin Faghihi, Elias Khalili Pour & Hamid Riazi-Esfahani. (2022) Evaluation of the additive effect of interferon α 2b with monthly intravitreal injection of bevacizumab in refractory diabetic macular edema. International Journal of Retina and Vitreous 8:1.
Crossref
Crossref
Weiye Shi, Xu Yao, Yu Fu & Yingze Wang. (2022) Interferon‑α and its effects on cancer cell apoptosis (Review). Oncology Letters 24:1.
Crossref
Crossref
Kyle M. Garland, Taylor L. Sheehy & John T. Wilson. (2022) Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy. Chemical Reviews 122:6, pages 5977-6039.
Crossref
Crossref
Iago Dillion Lima CavalcantiIago Dillion Lima Cavalcanti. 2022. Chemotherapy Protocols and Infusion Sequence. Chemotherapy Protocols and Infusion Sequence
27
55
.
Xuezhi Cao, Yong Liang, Zhenxiang Hu, Huiyu Li, Jiaming Yang, Eric J. Hsu, Jiankun Zhu, Jin Zhou & Yang-Xin Fu. (2021) Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance. Nature Communications 12:1.
Crossref
Crossref
Martina Musella, Claudia Galassi, Nicoletta Manduca & Antonella Sistigu. (2021) The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation. Biology 10:9, pages 856.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
197
226
.
Joan How & Gabriela Hobbs. (2020) Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature. Cancers 12:7, pages 1954.
Crossref
Crossref
Mehrdad Afarid, Aidin Meshksar, Alireza SalehiMohammad Mostafa Safarpour. (2020) EVALUATION OF THE EFFECT OF TOPICAL INTERFERON α2b AS A COMPLEMENTARY TREATMENT OF MACULAR EDEMA OF PATIENTS WITH DIABETIC RETINOPATHY. Retina 40:5, pages 936-942.
Crossref
Crossref
Laura Martin-Hijano & Bruno SainzJr.Jr.. (2020) The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway. Frontiers in Immunology 11.
Crossref
Crossref
Francesco Ciccarese, Angela Grassi, Lorenza Pasqualini, Stefania Rosano, Alessio Noghero, Francesca Montenegro, Federico Bussolino, Barbara Di Camillo, Lorenzo Finesso, Gianna Maria Toffolo, Stefania Mitola & Stefano Indraccolo. (2020) Genetic perturbation of IFN-α transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis. Computational and Structural Biotechnology Journal 18, pages 3977-3986.
Crossref
Crossref
Olivia K. Provance & Joan Lewis-Wambi. (2019) Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer. Breast Cancer Research 21:1.
Crossref
Crossref
Yaoyao YouChunbao GuoHan ZhangSijun DengJia TangLingqi XuChun DengFang Gong. (2019) Effect of Intranasal Instillation of Lipopolysaccharide on Lung Development and Its Related Mechanism in Newborn Mice. Journal of Interferon & Cytokine Research 39:11, pages 684-693.
Crossref
Crossref
Patrizia Mondello, Cristian Di Mirto, Salvatore Cuzzocrea, Carmela Arrigo, Michael Mian & Vincenzo Pitini. (2019) Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms. Clinical Lymphoma Myeloma and Leukemia 19:8, pages e489-e495.
Crossref
Crossref
Lucia Masarova, Prithviraj Bose & Srdan Verstovsek. (2019) The Rationale for Immunotherapy in Myeloproliferative Neoplasms. Current Hematologic Malignancy Reports 14:4, pages 310-327.
Crossref
Crossref
Natasha K. Brockwell & Belinda S. Parker. (2019) Tumor inherent interferons: Impact on immune reactivity and immunotherapy. Cytokine 118, pages 42-47.
Crossref
Crossref
Dhanush Haspula, Andrew K. Vallejos, Timothy M. Moore, Namrata Tomar, Ranjan K. Dash & Brian R. Hoffmann. (2019) Influence of a Hyperglycemic Microenvironment on a Diabetic Versus Healthy Rat Vascular Endothelium Reveals Distinguishable Mechanistic and Phenotypic Responses. Frontiers in Physiology 10.
Crossref
Crossref
Roberto Lande, Ernest Y. Lee, Raffaella Palazzo, Barbara Marinari, Immacolata Pietraforte, Giancarlo Santiago Santos, Yves Mattenberger, Francesca Spadaro, Katia Stefanantoni, Nicoletta Iannace, Aleksandra Maria Dufour, Mario Falchi, Manuela Bianco, Elisabetta Botti, Luca Bianchi, Montserrat Alvarez, Valeria Riccieri, Marie-Elise Truchetet, Gerard C.L. Wong, Carlo Chizzolini & Loredana Frasca. (2019) CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis. Nature Communications 10:1.
Crossref
Crossref
Adela García-Martín, Martín Garrido-Rodríguez, Carmen Navarrete, Diego Caprioglio, Belén Palomares, Jim DeMesa, Alain Rollland, Giovanni Appendino & Eduardo Muñoz. (2019) Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis. Biochemical Pharmacology 163, pages 321-334.
Crossref
Crossref
Jaesung Lim, Eunjin Cho, Kyungwoo Lee, Yonghyun Choi, Youngmin Seo, Hojeong Jeon & Jonghoon Choi. (2019) Current Immunotherapy Approaches for Malignant Melanoma. BioChip Journal 13:1, pages 105-114.
Crossref
Crossref
Thilo Hackert, Laura Wüsten & Markus W. Büchler. 2019. Tumor Angiogenesis. Tumor Angiogenesis
415
434
.
Linyu Geng, Shiying Wang, Xia Li, Dandan Wang, Haifeng Chen, Jinyun Chen, Yue Sun, Weiwei Chen, Genhong Yao, Xiang Gao, Wanjun Chen, Songtao Shi, Xuebing Feng & Lingyun Sun. (2018) Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand. Current Research in Translational Medicine 66:3, pages 71-82.
Crossref
Crossref
Megha Budhwani, Roberta Mazzieri & Riccardo Dolcetti. (2018) Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance. Frontiers in Oncology 8.
Crossref
Crossref
Ashwaq Yehya, Muhammad Asif, Sven Petersen, Ayappa Subramaniam, Koji Kono, Amin Majid & Chern Oon. (2018) Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis. Medicina 54:1, pages 8.
Crossref
Crossref
Haiyan Jia, Craig Thelwell, Paula Dilger, Chris Bird, Sarah Daniels & Meenu Wadhwa. (2018) Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy. Thrombosis Research 163, pages 105-116.
Crossref
Crossref
Cun‑Zhi Lin, Gui‑Ling Xiang, Xin‑Hong Zhu, Lu‑Lu Xiu, Jia‑Xing Sun & Xiao‑Yuan Zhang. (2018) Advances in the mechanisms of action of cancer-targeting oncolytic viruses (Review). Oncology Letters.
Crossref
Crossref
Lukasz Stawski, Grace Marden & Maria Trojanowska. (2018) The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway. The Journal of Immunology 200:1, pages 248-259.
Crossref
Crossref
Andreia Ribeiro, Rui M.V. Abreu, Madalena M. Dias, Maria Filomena Barreiro & Isabel C.F.R. Ferreira. (2017) Antiangiogenic compounds: well-established drugs versus emerging natural molecules. Cancer Letters.
Crossref
Crossref
Thilo Hackert, Laura Wüsten & Markus W. Büchler. 2017. Tumor Angiogenesis. Tumor Angiogenesis
1
20
.
Ann M. Kulungowski, Aladdin H. Hassanein, Carolyn C. Foster, Arin K. Greene & Steven J. Fishman. (2016) Bevacizumab and interferon reduce venous recanalization following sclerotherapy. Journal of Pediatric Surgery 51:10, pages 1670-1673.
Crossref
Crossref
Matteo Samuele Pizzuto, Micol Silic-Benussi, Vincenzo Ciminale, Ruth A. Elderfield, Ilaria Capua & Wendy S. Barclay. (2016) An engineered avian-origin influenza A virus for pancreatic ductal adenocarcinoma virotherapy. Journal of General Virology 97:9, pages 2166-2179.
Crossref
Crossref
Santo Landolfo & Marco De Andrea. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
485
493
.
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
207
230
.
Larissa A. Pikor, John C. Bell & Jean-Simon Diallo. (2015) Oncolytic Viruses: Exploiting Cancer's Deal with the Devil. Trends in Cancer 1:4, pages 266-277.
Crossref
Crossref
Natalie Spaccarelli & Alain H. Rook. (2015) The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma. Dermatologic Clinics 33:4, pages 731-745.
Crossref
Crossref
Giacomo Colletti, Pietro Dalmonte, Laura Moneghini, Daris Ferrari & Fabiana Allevi. (2015) Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations. Medical Hypotheses 85:3, pages 298-302.
Crossref
Crossref
Cansu YıldırımSylvia NieuwenhuisPaul F. TeunissenAnton J.G. HorrevoetsNiels van RoyenTineke C.T.M. van der Pouw Kraan. (2015) Interferon-Beta, a Decisive Factor in Angiogenesis and Arteriogenesis. Journal of Interferon & Cytokine Research 35:6, pages 411-420.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. (2015) The interferon-alpha revival in CML. Annals of Hematology 94:S2, pages 195-207.
Crossref
Crossref
Ana Sofia Cerdeira & Ravi Thadhani. (2015) Editorial: “Interfering” With Preeclampsia. Arthritis & Rheumatology 67:4, pages 862-864.
Crossref
Crossref
Ernest C. Borden. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
739
752.e7
.
Robbert M. Spaapen, Michael Y. K. Leung, Mercedes B. Fuertes, Justin P. Kline, Long Zhang, Yan Zheng, Yang-Xin Fu, Xixi Luo, Kenneth S. Cohen & Thomas F. Gajewski. (2014) Therapeutic Activity of High-Dose Intratumoral IFN-β Requires Direct Effect on the Tumor Vasculature. The Journal of Immunology 193:8, pages 4254-4260.
Crossref
Crossref
Carolina S. Ilkow, Stephanie L. Swift, John C. Bell & Jean-Simon Diallo. (2014) From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer. PLoS Pathogens 10:1, pages e1003836.
Crossref
Crossref
Swarna Mehrotra, Bhumika Sharma, Sonali Joshi, Barbara Kroczynska, Beata Majchrzak, Brady L. Stein, Brandon McMahon, Jessica K. Altman, Jonathan D. Licht, Darren P. Baker, Elizabeth A. Eklund, Amittha Wickrema, Amit Verma, Eleanor N. Fish & Leonidas C. Platanias. (2013) Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors. Journal of Biological Chemistry 288:33, pages 23814-23822.
Crossref
Crossref
Jessica Fioravanti, Jesús Prieto & Pedro Berraondo. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
441
452
.
Andrea Sgorbissa & Claudio Brancolini. (2012) IFNs, ISGylation and cancer: Cui prodest?. Cytokine & Growth Factor Reviews 23:6, pages 307-314.
Crossref
Crossref
Eiji Kajiwara, Aritune Ooho & Naoki Yamashita. (2012) Effectiveness of biweekly low-dosage peginterferon treatment on the improvement of serum alanine aminotransferase and α-fetoprotein levels. Hepatology Research 42:3, pages 254-263.
Crossref
Crossref
J I Quetglas, J Fioravanti, N Ardaiz, J Medina-Echeverz, I Baraibar, J Prieto, C Smerdou & P Berraondo. (2011) A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors. Gene Therapy 19:3, pages 271-278.
Crossref
Crossref
P. M. M. B. Soetekouw, A. Beeker, A. Bex, C. J. van Groeningen & P. F. A. Mulders. (2012) Bevacizumab in combinatie met interferon-alfa voor gemetastaseerd niercelcarcinoom: veiligheid en toepasbaarheid in de praktijk. Tijdschrift voor Urologie 1:8, pages 170-177.
Crossref
Crossref
Jean-Jacques KiladjianRuben A. Mesa & Ronald Hoffman. (2011) The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood 117:18, pages 4706-4715.
Crossref
Crossref
Christopher D Krause, Lara S Izotova, Gwangwen Ren, Zeng-Rong Yuan, Yufang Shi, Chiann-Chyi Chen, Yacov Ron & Sidney Pestka. (2011) Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid. Stem Cell Research & Therapy 2:2.
Crossref
Crossref
Anna S. Lok, James E. Everhart, Elizabeth C. Wright, Adrian M. Di Bisceglie, Hae–Young Kim, Richard K. Sterling, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, Marc G. Ghany, Chihiro Morishima & Timothy R. Morgan. (2011) Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C. Gastroenterology 140:3, pages 840-849.e1.
Crossref
Crossref
P.G. CorrieB. Basu & K. Ahmad Zaki. (2010) Targeting angiogenesis in melanoma: prospects for the future. Therapeutic Advances in Medical Oncology 2:6, pages 367-380.
Crossref
Crossref
Jing Xiao, Bing Sun & Guo-ping Cai. (2010) Transient Expression of Interferon-Inducible p204 in the Early Stage Is Required for Adipogenesis in 3T3-L1 Cells. Endocrinology 151:7, pages 3141-3153.
Crossref
Crossref
Steven A. Greenberg. (2010) Dermatomyositis and Type 1 Interferons. Current Rheumatology Reports 12:3, pages 198-203.
Crossref
Crossref